Anti-Human CD22 Recombinant Antibody (Moxetumomab Pasudotox) (CAT#: TAB-183-F(E))

Recombinant monoclonal antibody to CD22. Moxetumomab pasudotox is an anti-CD22 mouse monoclonal antibody designed for the treatment of cancer.

Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Fc Engineering:
  • Tested Data
  • Gene Expression
  • Datasheet
  • MSDS
  • COA
SDS-PAGE

Figure 1 Anti-Human CD22 Recombinant Antibody (TAB-183-F(E)) in SDS-PAGE

Figure 1 Anti-Human CD22 Recombinant Antibody (TAB-183-F(E)) in SDS-PAGE

SDS-PAGE analysis of TAB-183-F(E) in non-reduced (Lane 1). Gel stained for 30 minutes with Coomassie Blue. And non-reduced protein migrates as 70 kDa.

SEC-HPLC

Figure 2 Anti-Human CD22 Recombinant Antibody (TAB-183-F(E)) in HPLC

Figure 2 Anti-Human CD22 Recombinant Antibody (TAB-183-F(E)) in HPLC

HPLC analysis of TAB-183-F(E) shows the purity is>95%.


Specifications

  • Immunogen
  • The details of the immunogen for this antibody are not available.
  • Host Species
  • Mouse
  • Derivation
  • Mouse
  • Type
  • Fv - disulfide stabilized
  • Specificity
  • Tested positive against native human antigen.
  • Species Reactivity
  • Human
  • Applications
  • FuncS, IF, Neut, ELISA, FC, IP, ICC
  • CAS
  • 1020748-57-5
  • Generic Name
  • Moxetumomab pasudotox
  • MW
  • 63.5 kDa
  • Related Disease
  • Hairy cell leukemia (HCL)

Product Property

  • Purity
  • Purity >95% by SDS-PAGE.
  • Storage
  • Store it under sterile conditions at -20°C upon receiving. Recommend to pack the protein into smaller quantities for optimal storage.

Applications

  • Application Notes
  • The CD22 antibody has been reported in applications of PK, Cyt.

Target

  • Alternative Names
  • Moxetumomab pasudotox;1020748-57-5;CAT-8015;HA22;R490A;BL22 immunotoxin;CD22;CD22 molecule;CD22 antigen;B-cell receptor CD22;sialic acid binding Ig like lectin 2;SIGLEC 2;SIGLEC2;BL-CAM;T-cell surface antigen Leu-14;B-lymphocyte cell adhesion molecule;sia

Related Resources

  • Biosimilar Overview
Please refer to Moxetumomab Pasudotox Overview to learn more about the mechanism of action, clinical projects, and approved drugs of Moxetumomab Pasudotox.

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "CD22"

Select a product category from the dropdown menu below to view related products.
Please select product type
ScFv Antibody Products Humanized Antibody Products Immunotoxin Products Chimeric Antibody Products Human Antibody Products Mouse Antibody Products Fab Glycosylation Antibody Products Fc Glycosylation Antibody Products IgG Antibody Products Blocking Antibody Products Rabbit Monoclonal Antibody Products Fab Antibody Products ADCC Enhanced Antibody Products Antibody Magnetic Beads

Customer Reviews and Q&As

Submit a review or a question

There are currently no Customer reviews or questions for TAB-183-F(E). Click the button above to contact us or submit your feedback about this product.

Cite This Product

To accurately reference this product in your publication, please use the following citation information:

(Creative Biolabs Cat# TAB-183-F(E), RRID: AB_3111855)

Copy citation

Popular products with customers


For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

  • 0
  • 0
Cart
    Go to compare

    Go to compare